FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs.
作者:
主题词
乙酸盐类(Acetates);动物(Animals);抗肿瘤药(Antineoplastic Agents);临床试验(主题)(Clinical Trials as Topic);药物批准(Drug Approval);药物评价, 临床前(Drug Evaluation, Preclinical);氟尿嘧啶(Fluorouracil);人类(Humans);肿瘤(Neoplasms);研究设计(Research Design);治疗结果(Treatment Outcome);美国(United States);美国食品和药物管理局(United States Food and Drug Administration);尿苷(Uridine)
DOI
10.1158/1078-0432.CCR-16-0638
PMID
27401247
发布时间
2018-01-12
- 浏览10

Clinical cancer research
4545-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文